2026-2034年全球醫療保健領域人工智慧（AI）市場規模、佔有率、趨勢和成長分析報告

全球醫療保健領域人工智慧 (AI) 市場規模預計將從 2025 年的 340.2 億美元成長至 2034 年的 8,506.7 億美元，並預計在 2026 年至 2034 年期間以 43% 的複合年成長率成長。隨著醫療機構和技術開發公司將人工智慧應用於醫學影像、臨床決策支援、藥物研發、文件記錄、病患監測和行政管理等工作流程，該市場正在不斷擴張。醫療保健產業正在產生大量的臨床和營運數據，這些數據可以利用機器學習和其他人工智慧技術進行分析。醫院正擴大採用人工智慧工具來輔助臨床醫生並提高工作流程效率。製藥公司正在利用計算模型來加速研究，而數位醫療服務提供商正在開發由人工智慧驅動的患者支援應用程式。

醫學影像領域依然至關重要，因為人工智慧可以輔助影像分類、檢測、分割和優先排序。自然語言處理可以支援臨床記錄的創建和資訊提取，而生成式人工智慧正被探索用於摘要生成和工作流程支援。在藥物研發領域，人工智慧可以輔助標靶辨識、分子設計和病患篩選。人工智慧的應用取決於資料品質、互通性、臨床有效性、網路安全、隱私和監管要求等因素。人工監督仍然十分重要，尤其是在人工智慧的輸出結果會影響臨床決策的情況下。

醫療保健的持續數位化和機器學習能力的進步使未來前景光明。人工智慧系統可望與電子健康記錄、影像平台、實驗室系統和臨床工作流程更加緊密地整合。能夠處理文字、影像和其他醫療資料的多模態模型有望拓展其應用範圍。醫療機構將日益關注實證實踐、管治、透明度和可衡量的工作流程效益。隨著基礎設施和法律規範的日益成熟，人工智慧將更深入地融入具體的臨床、研究和行政流程中。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭動態以及主要參與者所採取的策略。

市場預測：本部分提供以資料為基礎的市場規模和成長模式展望，預測期為指定期間。它綜合考慮歷史趨勢、當前市場狀況和定量分析，揭示未來發展趨勢。

區域分析：我們全面檢驗主要地理區域的市場趨勢，並識別高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球醫療保健產業人工智慧（AI）市場：按組件分類

• 市場分析、洞察與預測
• 硬體
• 軟體
• 服務

第5章：全球醫療保健領域人工智慧（AI）市場：按應用領域分類

• 市場分析、洞察與預測
• 醫療管理和支持
• 病患管理
• 研究與藥物發現
• 診斷和影像診斷

第6章：全球醫療保健領域人工智慧（AI）市場：按技術分類

• 市場分析、洞察與預測
• 機器學習
• 自然語言處理
• 電腦視覺
• 情境感知計算
• 專家系統與機器人技術

第7章：全球醫療保健產業人工智慧（AI）市場：按最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 製藥和生物技術公司
• 診斷檢查室
• 付款人和保險
• 受託研究機構

第8章：全球醫療保健產業人工智慧（AI）市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • IBM Corporation
  • Microsoft Corporation
  • Google LLC（incl. DeepMind Technologies Ltd.）
  • NVIDIA Corporation
  • Amazon Web Services Inc
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc
  • Medtronic Plc
  • Atomwise Inc
  • Modernizing Medicine Inc
  • Nano-X Imaging Ltd
  • Medasense Biometrics Ltd
  • BPGbio Inc
  • Sense.ly Corporation
  • AiCure LLC
  • Cyrcadia Health Inc

The global artificial intelligence in medicine market size is expected to reach USD 850.67 Billion in 2034 from USD 34.02 Billion in 2025, growing at a CAGR of 43% during 2026-2034.This market is expanding as healthcare organizations and technology developers apply artificial intelligence to medical imaging, clinical decision support, drug discovery, documentation, patient monitoring, and administrative workflows. Healthcare generates large volumes of clinical and operational data that can be analyzed using machine learning and other AI technologies. Hospitals are exploring AI tools to support clinicians and improve workflow efficiency. Pharmaceutical companies are also using computational models to accelerate research, while digital-health providers are developing AI-enabled patient-support applications.

Medical imaging remains an important area because AI can assist with image classification, detection, segmentation, and prioritization. Natural-language processing can support clinical documentation and information extraction, while generative AI is being explored for summarization and workflow assistance. In pharmaceutical research, AI can support target identification, molecule design, and patient selection. Adoption depends on factors including data quality, interoperability, clinical validation, cybersecurity, privacy, and regulatory requirements. Human oversight remains important, particularly when AI outputs influence clinical decisions.

Future prospects are supported by continued digitization of healthcare and advances in machine learning capabilities. AI systems are likely to become more integrated with electronic health records, imaging platforms, laboratory systems, and clinical workflows. Multimodal models capable of processing text, images, and other healthcare data could expand potential applications. Healthcare organizations will increasingly focus on evidence, governance, transparency, and measurable workflow benefits. As infrastructure and regulatory frameworks mature, AI can become more deeply embedded in selected clinical, research, and administrative processes.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Component

• Hardware
• Software
• Services

By Application

• Medical Administration and Support
• Patient Management
• Research and Drug Discovery
• Diagnostics and Imaging

By Technology

• Machine Learning
• Natural-Language Processing
• Computer Vision
• Context-Aware Computing
• Expert Systems and Robotics

By End User

• Hospitals and Clinics
• Pharmaceutical and Biotech Firms
• Diagnostic Laboratories
• Payers and Insurance
• Contract Research Organizations

COMPANIES PROFILED

• IBM Corporation, Microsoft Corporation, Google LLC (incl. DeepMind Technologies Ltd.), NVIDIA Corporation, Amazon Web Services Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medtronic plc, Atomwise Inc., Modernizing Medicine Inc., Nano-X Imaging Ltd., Medasense Biometrics Ltd., BPGbio Inc., Sense.ly Corporation, AiCure LLC, Cyrcadia Health Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Medical Administration and Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Patient Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Research and Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Diagnostics and Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Machine Learning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Natural-Language Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Computer Vision Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Context-Aware Computing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Expert Systems and Robotics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical and Biotech Firms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Payers and Insurance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Component
  • 8.2.2 By Application
  • 8.2.3 By Technology
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Component
  • 8.3.2 By Application
  • 8.3.3 By Technology
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Component
  • 8.4.2 By Application
  • 8.4.3 By Technology
  • 8.4.4 By End User
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Component
  • 8.5.2 By Application
  • 8.5.3 By Technology
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Component
  • 8.6.2 By Application
  • 8.6.3 By Technology
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 IBM Corporation
  • 10.2.2 Microsoft Corporation
  • 10.2.3 Google LLC (incl. DeepMind Technologies Ltd.)
  • 10.2.4 NVIDIA Corporation
  • 10.2.5 Amazon Web Services Inc
  • 10.2.6 Siemens Healthineers AG
  • 10.2.7 Koninklijke Philips N.V
  • 10.2.8 GE HealthCare Technologies Inc
  • 10.2.9 Medtronic Plc
  • 10.2.10 Atomwise Inc
  • 10.2.11 Modernizing Medicine Inc
  • 10.2.12 Nano-X Imaging Ltd
  • 10.2.13 Medasense Biometrics Ltd
  • 10.2.14 BPGbio Inc
  • 10.2.15 Sense.ly Corporation
  • 10.2.16 AiCure LLC
  • 10.2.17 Cyrcadia Health Inc